In terms of market side, this report researches the T-cell Therapy revenue, growth rate, market share by manufacturers, by type, by application and by region (region level and country level), from 2019 to 2024, and forecast to 2030.
The global T-cell Therapy market size in 2023 is 5592.5 million US dollars, and it is expected to be 47485.4 million US dollars by 2030, with a compound annual growth rate of 35.7% expected in 2024-2030.
MARKET COMPETITIVE LANDSCAPE:
The main players in the T-cell Therapy market include Pfizer Inc., Fate Therapeutics, Sorrento Therapeutics, TCR2 Therapeutics Inc, and Bluebird Bio Inc.. The share of the top 3 players in the T-cell Therapy market is XX%.
REGION SHARE:
The report covers the market size information of North America, Europe, Asia Pacific, Latin America, Middle East and Africa, and North America accounted for XX%, Europe accounted for XX% of T-cell Therapy market, and Asia Pacific accounted for XX%.
SEGMENT OVERVIEW:
The report segments the market by Type and Application. CAR T-cell Therapy accounted for XX% of T-cell Therapy market in 2023. T Cell Receptor (TCR)-based share of XX%.
Hospitals accounted for XX% of the T-cell Therapy market in 2023. Cancer Treatment Centers accounts for XX%.
Report Includes:
This report presents an overview of global market for T-cell Therapy. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key players of T-cell Therapy, also provides the consumption of main regions and countries. Highlights of the upcoming market potential for T-cell Therapy, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the T-cell Therapy market share and industry ranking of main players, data from 2019 to 2024. Identification of the major stakeholders in the global T-cell Therapy market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, from 2019 to 2030. Evaluation and forecast the market size for T-cell Therapy sales, projected growth trends, technology, application and end-user industry.
Chapter Outline
Chapter 1: Introduces the product overview, market scope, product classification, application, and regional division, and then includes inflation analysis, the impact of the Russo-Ukrainian war on the market, and the global impact of the coronavirus disease (COVID-19).
Chapter 2: Analysis of the competitive environment of T-cell Therapy market participants. This mainly includes the revenue and market share of the top players, along with the players” M&A and expansion in recent years.
Chapter 3: Analyzes the main companies in the T-cell Therapy industry, including their main businesses, products/services, revenue, gross margin, and the latest developments.
Chapters 4-6: Segmented the global T-cell Therapy market by type, application and region. Analyze the revenue of market segments from different perspectives.
Chapters 7-10: Provide Americas, Europe, Asia Pacific and Middle East and Africa T-cell Therapy market type, application and country market segmentation data.
Chapter 11: Introduces the market dynamics, the trends factors and drivers factors of the market, and the challenges and restraints faced by manufacturers in the industry.
Chapters 12-14: Provide detailed T-cell Therapy market forecast data, broken down by type, application, and region to help understand future growth trends.
Chapter 15: The main points and conclusions of the report.
Chapter 16: Concludes with an explanation of the data sources and research methods.
Highlights-Regions
Americas
United States
Canada
Brazil
Argentina
Mexico
Europe
Germany
France
UK
Italy
Russia
Asia Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
MEA
Saudi Arabia
UAE
Turkey
Player list
Pfizer Inc.
Fate Therapeutics
Sorrento Therapeutics
TCR2 Therapeutics Inc
Bluebird Bio Inc.
Gilead Sciences Inc.
Merck KGaA
Novartis AG
Amgen
Celgene Corporation
Types list
CAR T-cell Therapy
T Cell Receptor (TCR)-based
Tumor Infiltrating Lymphocytes (TIL)-based
Application list
Hospitals
Cancer Treatment Centers
List of Tables and Figures
Figure T-cell Therapy Picture
Table Product Definition of T-cell Therapy
Table Global T-cell Therapy Market Size Growth Rate by Type, 2019 VS 2024 VS 2030
Table Global T-cell Therapy Market Size Growth Rate by Application, 2019 VS 2024 VS 2030
Table Global T-cell Therapy Market by Region: 2019 VS 2024 VS 2030
Figure Global T-cell Therapy Revenue Market Size & Forecasts 2019-2030
Figure Years Considered
Table Inflation Analysis
Table The Impact of the Russian-Ukrainian War on the Market
Figure (COVID-19) Impact on Global Economic Growth 2019, 2020, 2021
Figure Population infected by the Covid-19 of Major Countries
Table Global T-cell Therapy Revenue by Players (2019-2024)
Table Global T-cell Therapy Revenue Market Share by Players (2019-2024)
Figure Top 5 Largest Players of T-cell Therapy in 2024
Figure Top 10 Largest Players of T-cell Therapy in 2024
Table Global T-cell Therapy Gross Margin by Players
Table Players Market Concentration Ratio (CR5)
Table Global T-cell Therapy Players Geographical Distribution
Table Mergers & Acquisitions, Expansion Plans
Table Company Profiles
Table Pfizer Inc. Overview
Table Pfizer Inc. Revenue, Gross, Gross Margin 2019-2024
Table Pfizer Inc. Related Developments
Table Company Profiles
Table Fate Therapeutics Overview
Table Fate Therapeutics Revenue, Gross, Gross Margin 2019-2024
Table Fate Therapeutics Related Developments
Table Company Profiles
Table Sorrento Therapeutics Overview
Table Sorrento Therapeutics Revenue, Gross, Gross Margin 2019-2024
Table Sorrento Therapeutics Related Developments
Table Company Profiles
Table TCR2 Therapeutics Inc Overview
Table TCR2 Therapeutics Inc Revenue, Gross, Gross Margin 2019-2024
Table TCR2 Therapeutics Inc Related Developments
Table Company Profiles
Table Bluebird Bio Inc. Overview
Table Bluebird Bio Inc. Revenue, Gross, Gross Margin 2019-2024
Table Bluebird Bio Inc. Related Developments
Table Company Profiles
Table Gilead Sciences Inc. Overview
Table Gilead Sciences Inc. Revenue, Gross, Gross Margin 2019-2024
Table Gilead Sciences Inc. Related Developments
Table Company Profiles
Table Merck KGaA Overview
Table Merck KGaA Revenue, Gross, Gross Margin 2019-2024
Table Merck KGaA Related Developments
Table Company Profiles
Table Novartis AG Overview
Table Novartis AG Revenue, Gross, Gross Margin 2019-2024
Table Novartis AG Related Developments
Table Company Profiles
Table Amgen Overview
Table Amgen Revenue, Gross, Gross Margin 2019-2024
Table Amgen Related Developments
Table Company Profiles
Table Celgene Corporation Overview
Table Celgene Corporation Revenue, Gross, Gross Margin 2019-2024
Table Celgene Corporation Related Developments
Figure Global T-cell Therapy Market Revenue 2019-2024
Table Global T-cell Therapy Revenue by Region (2019-2024)
Table Global T-cell Therapy Revenue Share by Region (2019-2024)
Figure Americas T-cell Therapy Revenue (2019-2024)
Figure Europe T-cell Therapy Revenue (2019-2024)
Figure Asia-Pacific T-cell Therapy Revenue (2019-2024)
Figure Middle East & Africa T-cell Therapy Revenue (2019-2024)
Table Global T-cell Therapy Revenue by Type (2019-2024)
Table Global T-cell Therapy Revenue Share by Type (2019-2024)
Table Global T-cell Therapy Revenue by Application (2019-2024)
Table Global T-cell Therapy Revenue Share by Application (2019-2024)
Table Americas T-cell Therapy Revenue by Type (2019-2024)
Table Americas T-cell Therapy Revenue Share by Type (2019-2024)
Table Americas T-cell Therapy Revenue by Application (2019-2024)
Table Americas T-cell Therapy Revenue Share by Application (2019-2024)
Table Americas T-cell Therapy Revenue by Country (2019-2024)
Table Americas T-cell Therapy Revenue Share by Country (2019-2024)
Figure United States T-cell Therapy Revenue Market Size (2019-2024)
Figure Canada T-cell Therapy Revenue Market Size (2019-2024)
Figure Mexico T-cell Therapy Revenue Market Size (2019-2024)
Figure Brazil T-cell Therapy Revenue Market Size (2019-2024)
Figure Argentina T-cell Therapy Revenue Market Size (2019-2024)
Table Europe T-cell Therapy Revenue by Type (2019-2024)
Table Europe T-cell Therapy Revenue Share by Type (2019-2024)
Table Europe T-cell Therapy Revenue by Application (2019-2024)
Table Europe T-cell Therapy Revenue Share by Application (2019-2024)
Table Europe T-cell Therapy Revenue by Country (2019-2024)
Table Europe T-cell Therapy Revenue Share by Country (2019-2024)
Figure Germany T-cell Therapy Revenue Market Size (2019-2024)
Figure France T-cell Therapy Revenue Market Size (2019-2024)
Figure U.K. T-cell Therapy Revenue Market Size (2019-2024)
Figure Italy T-cell Therapy Revenue Market Size (2019-2024)
Figure Russia T-cell Therapy Revenue Market Size (2019-2024)
Table Asia Pacific T-cell Therapy Revenue by Type (2019-2024)
Table Asia Pacific T-cell Therapy Revenue Share by Type (2019-2024)
Table Asia Pacific T-cell Therapy Revenue by Application (2019-2024)
Table Asia Pacific T-cell Therapy Revenue Share by Application (2019-2024)
Table Asia Pacific T-cell Therapy Revenue by Region (2019-2024)
Table Asia Pacific T-cell Therapy Revenue Share by Region (2019-2024)
Figure China T-cell Therapy Revenue Market Size (2019-2024)
Figure Japan T-cell Therapy Revenue Market Size (2019-2024)
Figure South Korea T-cell Therapy Revenue Market Size (2019-2024)
Figure India T-cell Therapy Revenue Market Size (2019-2024)
Figure Southeast Asia T-cell Therapy Revenue Market Size (2019-2024)
Figure Australia T-cell Therapy Revenue Market Size (2019-2024)
Table Middle East and Africa T-cell Therapy Revenue by Type (2019-2024)
Table Middle East and Africa T-cell Therapy Revenue Share by Type (2019-2024)
Table Middle East and Africa T-cell Therapy Revenue by Application (2019-2024)
Table Middle East and Africa T-cell Therapy Revenue Share by Application (2019-2024)
Table Middle East and Africa T-cell Therapy Revenue by Country (2019-2024)
Table Middle East and Africa T-cell Therapy Revenue Share by Country (2019-2024)
Figure Turkey T-cell Therapy Revenue Market Size (2019-2024)
Figure Saudi Arabia T-cell Therapy Revenue Market Size (2019-2024)
Figure U.A.E T-cell Therapy Revenue Market Size (2019-2024)
Table Global T-cell Therapy Forecasted Revenue by Type (2019-2024)
Table Global T-cell Therapy Forecasted Revenue Share by Type (2019-2024)
Table Global T-cell Therapy Forecasted Revenue by Application (2019-2024)
Table Global T-cell Therapy Forecasted Revenue Share by Application (2019-2024)
Figure Global T-cell Therapy Market Revenue Forecasts 2024-2030
Table Global T-cell Therapy Forecasts Revenue by Region (2024-2030)
Table Global T-cell Therapy Forecasts Revenue Share by Region (2024-2030)
Figure Americas T-cell Therapy Forecasts Revenue and Growth (2024-2030)
Table Americas T-cell Therapy Forecasts Revenue by Country (2019-2024)
Table Americas T-cell Therapy Forecasts Revenue Share by Country (2019-2024)
Figure Europe T-cell Therapy Forecasts Revenue and Growth (2024-2030)
Table Europe T-cell Therapy Forecasts Revenue by Country (2019-2024)
Table Europe T-cell Therapy Forecasts Revenue Share by Country (2019-2024)
Figure Asia-Pacific T-cell Therapy Forecasts Revenue and Growth (2024-2030)
Table Asia Pacific T-cell Therapy Forecasts Revenue by Country (2019-2024)
Table Asia Pacific T-cell Therapy Forecasts Revenue Share by Country (2019-2024)
Figure Middle East & Africa T-cell Therapy Forecasts Revenue and Growth (2024-2030)
Table Middle East and Africa T-cell Therapy Forecasts Revenue by Country (2019-2024)
Table Middle East and Africa T-cell Therapy Forecasts Revenue Share by Country (2019-2024)
Table Research Process
Figure Bottom-up and Top-down Approaches for This Report
